WHAT'S NEW IN CD Promo WorldWide TODAY! |
||
 |
|
|
AS OF NOW THERE ARE. .
2,628,712
total promotional images in the CD Promo
WorldWide database
DATABASE BREAKDOWN
Mouse over the image on the left to view a infographic that shows how the CD Promo WorldWide database is broken down by object type.
CD Promo WorldWide FREE TRIAL
Get a free trial of the largest and most comprehensive
digital library of all types of promotional material dating
back to 1996. Click here to sign up for your free trial.
INDUSTRY NEWS
Antimicrobials (Antibiotics)
FDA Advisory Committee Recommends Approval of Forest Laboratories' Ceftaroline Fosamil for the Treatment of Community Acquired Bacterial Pneumonia and Complicated Skin and Skin Structure Infections
from PharmaLive - September 8, 2010
CNS (Antipsychotics)
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asenapine) Sublingual Tablets
from PharmaLive - September 8, 2010
Respiratory/Allergy (Asthma)
QVAR® Versus Fluticasone in a Real-World Study Highlights the Importance of Inhaled Corticosteroid (ICS) Choice in Achieving Asthma Control
from FiercePharma - September 8, 2010
PUBLISHED REPORTS
E-Sampling Programs; The Physician Perspective
Interim Summary Report of Response from:
Primary Care Physicians, Endocrinologist, Psychiatrists, Pain Specialists, Cardiologists, and Oncologists
Email for more information
PPI Risk of Fracture and IMPACT Assessement Study
Email for more information
The FDA Review of LABAs and LABA Containing Products - The Physician Perspective (Wave 1 & 2) IMPACT Assessment Study
Email for more information
Preparing for Loss of Patent in 2010/2011: An Analysis of Promotional Materials
Including summaries on promotional strategies for
Cozaar/Hyzaar, CellCept, Prograf, Protonix
Email for more information
COMING SOON
Vimovo CD PROMO Message View Post-Launch Tracking Study
Email for more information
The FDA Review of Risks Associated with Benicar; An Impact Assessment Study
Email for more information
Fanapt, Invega Sustenna, Seroquel XR and Saphris; New Sales Messages (Wave 2); A CD Promo Message View Study
Email for more information
E-Communications, E-Detailing and Internet Based Promotion - The Physician Perspective (Wave 4)
Email for more information
IMPACT Assessment Study: The FDA Review of LABAs and LABA Containing Products - The Physician Perspective (Wave 3)
Email for more information
Multi-Channel Marketing Preferences, The Physician Perspective
Email for more information
